Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease
This study has been completed.
Study NCT00623324   Information provided by Ligand Pharmaceuticals

First Received on February 14, 2008.   Last Updated on September 29, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Early Stage Parkinson's Disease
Additional conditions recognized in this trial
Parkinson Disease
Signs and Symptoms
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders
Interventions listed in this trial
Aplindore
Placebo
Sponsors listed in this trial
Ligand Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services